HMGB1 and central nervous system cancer: In the present study, the expression of HMGB1 was examined in 15 samples of normal brain tissue and 65 samples of different-grade glioma tissue by immunohistochemistry and western blot analysis, and the associations between the expression level and pathology grades were analyzed statistically to investigate the clinical significance.